Analysts Set Oscar Health, Inc. (NYSE:OSCR) PT at $15.57

Oscar Health, Inc. (NYSE:OSCR) has received an average recommendation of “Reduce” from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $15.5714.

A number of brokerages recently issued reports on OSCR. The Goldman Sachs Group initiated coverage on Oscar Health in a research note on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price objective on the stock. Stephens initiated coverage on shares of Oscar Health in a research report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 price target on the stock. Piper Sandler upgraded shares of Oscar Health from a “neutral” rating to an “overweight” rating and upped their price target for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Finally, Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th.

Insider Buying and Selling

In other news, insider Adam Mcananey sold 1,852 shares of the company’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $30,724.68. Following the sale, the insider directly owned 179,241 shares in the company, valued at $2,973,608.19. This represents a 1.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Richard Scott Blackley sold 25,135 shares of the stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $416,989.65. Following the completion of the sale, the chief financial officer directly owned 1,351,034 shares in the company, valued at approximately $22,413,654.06. The trade was a 1.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 383,307 shares of company stock valued at $5,919,555. 25.11% of the stock is owned by company insiders.

Institutional Trading of Oscar Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. American Century Companies Inc. boosted its holdings in Oscar Health by 89.0% in the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock valued at $100,298,000 after purchasing an additional 2,495,691 shares during the period. Farallon Capital Management LLC raised its position in shares of Oscar Health by 146.5% in the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after buying an additional 2,163,000 shares in the last quarter. Thrive Capital Management LLC boosted its stake in Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares during the period. State of Michigan Retirement System purchased a new position in Oscar Health during the third quarter worth about $27,448,000. Finally, Jump Financial LLC increased its stake in Oscar Health by 798.3% in the 2nd quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock worth $30,906,000 after acquiring an additional 1,281,032 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 0.2%

NYSE:OSCR opened at $14.50 on Friday. Oscar Health has a 12 month low of $11.20 and a 12 month high of $23.80. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. The firm’s 50 day moving average is $16.31 and its 200 day moving average is $17.08. The stock has a market capitalization of $3.84 billion, a PE ratio of -12.94 and a beta of 1.88.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The business had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. During the same period last year, the business posted ($0.22) earnings per share. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. Sell-side analysts expect that Oscar Health will post 0.69 earnings per share for the current year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.